Patent details
EP2444090 Title: Novel parenteral carbamazepine formulation
Basic Information
- Publication number:
- EP2444090
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP121507834
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Novel parenteral carbamazepine formulation
- French Title of Invention:
- Nouvelle formulation parentérale de carbamazépine
- German Title of Invention:
- Neuartige parenterale Carbamazepinformulierung
- SPC Number:
Dates
- Filing date:
- 02/10/2006
- Grant date:
- 12/12/2018
- EP Publication Date:
- 25/04/2012
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/12/2018
- EP B1 Publication Date:
- 12/12/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/10/2019
- Expiration date:
- 02/10/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/12/2018
- Name:
- Lundbeck Pharmaceuticals LLC
- Address:
- 6 Parkway North, Suite 400, Deerfield, IL 60015, United States (US)
Inventor
1
- Name:
- Leppik, Ilo
- Address:
- United States (US)
2
- Name:
- Cloyd, James
- Address:
- United States (US)
3
- Name:
- Birnbaum, Angela
- Address:
- United States (US)
Priority
- Priority Number:
- 722692 P
- Priority Date:
- 30/09/2005
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/55;
Publication
European Patent Bulletin
- Issue number:
- 201850
- Publication date:
- 12/12/2018
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|